Search...
Herbalife jumps after Argus Research upgrades to 'buy'
I'm PortAI, I can summarize articles.
Herbalife's stock rose 11% to $13.11 after Argus Research upgraded it to 'buy' from 'hold', citing confidence in its turnaround and growth prospects. The firm expects mid-single-digit growth in 2025, driven by new products. Herbalife shares have surged 80% in six months, outperforming the Consumer Staples ETF. Argus warns of potential volatility, recommending the stock for risk-tolerant investors. Currently, 2 out of 4 brokerages rate it as 'buy' or higher.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments